SUVmax Predicts Disease Progression after Stereotactic Ablative Radiotherapy in Stage I Non-small Cell Lung Cancer

PURPOSE: Fluorodeoxyglucose positron emission tomography–computed tomography (PET-CT) is gaining evidence as a predictive factor in non-small cell lung cancer (NSCLC). Stereotactic ablative radiotherapy (SABR) is the standard treatment in early-stage NSCLC when a patient is unsuitable for surgery. W...

Descripción completa

Detalles Bibliográficos
Autores principales: Kwak, Yoo-Kang, Park, Hee Hyun, Choi, Kyu Hye, Park, Eun Young, Sung, Soo Yoon, Lee, Sea-Won, Hong, Ji Hyun, Lee, Hyo Chun, Yoo, Ie Ryung, Kim, Yeon Sil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6962475/
https://www.ncbi.nlm.nih.gov/pubmed/31122008
http://dx.doi.org/10.4143/crt.2019.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6962475/
https://www.ncbi.nlm.nih.gov/pubmed/31122008
http://dx.doi.org/10.4143/crt.2019.007

Ejemplares similares